Skip to content

Hepatitis Health Center

Select An Article
Font Size

References

Citations

  1. Terrault NA, et al. (2013). Sexual transmission of hepatitis C virus among monogamous heterosexual couples: The HCV Partners Study. Hepatology, 57(3): 881–889.

  2. Dienstag JL (2010). Chronic viral hepatitis. In GL Mandell et al., eds., Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed., vol. 1, pp. 1593–1670. Philadelphia: Churchill Livingstone Elsevier.

  3. Flamm SL (2003). Chronic hepatitis C virus infection. JAMA, 289(18): 2413–2417.

  4. Smith BD, et al. (2012). Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965. MMWR, 61(RR-4): 1–32. Available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6104a1.htm.

  5. U.S. Preventive Services Task Force (2013). Screening for Hepatitis C Virus Infection in Adults: Recommendation Statement. Available online: http://www.uspreventiveservicestaskforce.org/uspstf/uspshepc.htm.

  6. Wiegand J, et al. (2006). Early monotherapy with pegylated interferon alfa-2b for acute hepatitis C infection: The HEP-NET Acute HCV-II Study. Hepatology, 43(2): 250–256.

  7. Centers for Disease Control and Prevention (2012). Hepatitis C FAQs for health professionals. Available online: http://www.cdc.gov/hepatitis/HCV/HCVfaq.htm.

  8. Ward RP, et al. (2004). Management of hepatitis C: Evaluating suitability for drug therapy. American Family Physician, 69(6): 1429–1438.

  9. Singal AK, et al. (2010). Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis, Clinical Gastroenterology and Hepatology, 8(2): 192–199.

  10. Morgan RL, et al. (2013). Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: A meta-analysis of observational studies. Annals of Internal Medicine, 158(5, Part 1): 329–337.

  11. Ghany MG, et al. (2011). An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology, 54(4): 1433–1444. Also available online: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229841.

  12. Ghany MG, et al. (2009). Diagnosis, management, and treatment of hepatitis C: An update. Hepatology, 49(4): 1335–1374. Also available online: http://onlinelibrary.wiley.com/doi/10.1002/hep.22759/full.

  13. Pawlotsky JM, McHutchinson J (2012). Chronic viral and autoimmune hepatitis. In L Goldman, A Shafer, eds., Goldman's Cecil Medicine, 24th ed., pp. 973–979. Philadelphia: Saunders.

  14. Bacon BR, et al. (2011). Boceprevir for previously treated chronic HCV genotype 1 infection. New England Journal of Medicine, 364(13): 1207–1217.

  15. U.S. Food and Drug Administration (2009). Consumer advisory: Kava-containing dietary supplements may be associated with severe liver injury. Available online: http://www.fda.gov/Food/ResourcesForYou/Consumers/ucm085482.htm.

  16. National Center for Complementary and Alternative Medicine (2012). Get the Facts: Hepatitis C: A Focus on Herbal Supplements (NCCAM Publication No. D422). Washington, DC: U.S. National Institutes of Health. Available online: http://nccam.nih.gov/health/hepatitisc/hepatitiscfacts.htm.

  17. Fried MW, et al. (2012). Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: A randomized controlled trial. JAMA, 308(3): 274–282.

Other Works Consulted

  • Centers for Disease Control and Prevention (2005). Guidelines for Viral Hepatitis Surveillance and Case Management. Available online: http://www.cdc.gov/hepatitis/Statistics/SurveillanceGuidelines.htm.

  • Craxi A, Licata A (2006). Acute hepatitis C: In search of the optimal approach to cure. Hepatology, 43(2): 221–224.

  • Everson GT, et al. (2008). Quantitative tests of liver function measure hepatic improvement after sustained virological response: Results from the HALT-C trial. Alimentary Pharmacology and Therapeutics, 29(5): 589–601.

  • Mack CL, et al. (2012). NASPGHAN practice guidelines: Diagnosis and management of hepatitis C infection in infants, children, and adolescents. Journal of Pediatric Gastroenterology and Nutrition, 54(6): 838–855.

  • Maylin S, et al. (2008). Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C. Gastroenterology, 135(3): 821–829.

  • Mohsen A, Norris S (2010). Hepatitis C (chronic), search date April 2008. Online version of BMJ Clinical Evidence: http://www.clinicalevidence.com.

WebMD Medical Reference from Healthwise

Last Updated: August 15, 2013
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.
Next Article:

Today on WebMD

Hepatitus C virus
Types, symptoms and treatments.
liver illustration
Myths and facts about this essential organ.
 
woman eating apple
What you need to know.
doctor and patient
What causes it?
 
Hepatitis C Treatment
Article
Syringes and graph illustration
Tool
 
liver illustration
Quiz
passport, pills and vaccine
Slideshow
 
Scientist looking in microscope
Slideshow
Fatty Liver Disease
Article
 
Digestive Diseases Liver Transplantation
Article
Picture Of The Liver
Image Collection